Every year, millions of people suffer from incontinence and related problems, especially in the U.K. Overweight people, males with prostate disease, pregnant women, and athletes are at a higher risk of incontinence. Parkinson’s disease, stroke, multiple sclerosis, spina bifida, arthritis, and diabetes may also increase the possibility of incontinence.
Rising occurrence of inflammatory bowel diseases, the increasing patient awareness, and the introduction of innovative skin care and body wash products are predicted to propel the U.K. incontinence skin care and body wash market. The rising government funding and enhanced R&D activities for new product development are expected to drive the global market in the near future.
Transparency Market Research (TMR), a leading business intelligence firm, in its recent research report, states that the U.K. incontinence skin care and body wash market stood at US$38.7 mn in 2014. The U.K. market is expected to reach US$50.1 mn by 2023, progressing at a 2.60% CAGR from 2015 to 2023. TMR experts answer a few questions related to the U.K. incontinence skin care and body wash market:
Q. How would the introduction of new products benefit the global market?
A. Over the past few years, the global medical devices market has been experiencing exceptional growth due to the introduction of new products.
Kimberly-Clark Corporation, a leader in the U.K. incontinence skin care market, was in the news for its new set of products. Kimberly-Clark Corporation recently added new varieties to its adult care products range, namely, Depend, Poise, and Plenitud.
Male incontinence has become a common problem across the world, especially in the United Kingdom. To this end, B. Braun Melsungen AG, has introduced new urinary incontinence solutions for male patients. The company recently launched its new line of incontinence skin care product, Urimed Vision, to its existing products such as Urimed leg bags. The feature that differentiates Urimed Vision from other products is that it is made from 100% silicon.
Recently, Svenska Cellulosa Aktiebolaget SCA announced its support for the formation of an international incontinence research and care center in Gothenburg, Sweden. With this, SCA aims to offer state-of-the-art incontinence care and solutions. The Gothenburg Continence Research Center (GCRC) will be engaged in research and development activities to introduce new incontinence skin care solutions. This move is projected to have a positive impact on the overall incontinence skin care market in Europe.
Q. How will surgical alternatives threaten the global incontinence skin care and body wash market?
With advancements in the surgical equipment, people opt for surgical procedures to permanently treat any health issues. Companies operating in the healthcare industry offer many affordable surgical procedures to treat incontinence. Tape procedures, colposuspension, sling procedures, urethral bulking agents, and artificial urinary sphincter are some of the procedures to treat incontinence. The availability of many surgical alternatives is expected to threaten the growth of the global market.
Further, uncertain reimbursement policies may also hamper the growth of the global incontinence skin care and body wash market.
Q. How could the aging population create growth opportunities?
As per the World Health Organization, approximately 8-9% of the global population is currently suffering from incontinence of the bowel or bladder. People aged 60 years and above are the largest target patrons for the manufacturers of incontinence skin care and body wash products, accounting for 82.3% of the total customers. The rising aging population is one of the factors expected to drive the global incontinence skin care and body wash market.